diversion aspartate ass1-deficient tumours fosters de novo pyrimidine synthesis 
cancer cells hijack remodel existing metabolic pathways benefit argininosuccinate synthase ass1 urea cycle enzyme essential conversion nitrogen ammonia aspartate urea decrease nitrogen flux ass1 liver causes urea cycle disorder citrullinaemia contrast well-studied consequences loss ass1 activity ureagenesis purpose somatic silencing multiple cancers largely unknown show decreased activity ass1 cancers supports proliferation facilitating pyrimidine synthesis via cad carbamoyl-phosphate synthase aspartate transcarbamylase dihydroorotase complex activation studies initiated delineating consequences loss ass1 activity humans two types citrullinaemia find citrullinaemia type ctln caused deficiency ass1 increased pyrimidine synthesis proliferation compared citrullinaemia type ii ctln ii decreased substrate availability ass1 caused deficiency aspartate transporter citrin building results demonstrate ass1 deficiency cancer increases cytosolic aspartate levels increases cad activation upregulating substrate availability increasing phosphorylation s6k1 mammalian target rapamycin mtor pathway decreasing cad activity blocking citrin mtor signalling pyrimidine synthesis decreases proliferation thus may serve therapeutic strategy multiple cancers ass1 downregulated results demonstrate ass1 downregulation novel mechanism supporting cancerous proliferation provide metabolic link urea cycle enzymes pyrimidine synthesis 
